{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:45:12Z","timestamp":1790473512568,"version":"4.1.0"},"reference-count":72,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Patients with diabetes mellitus (DM) have chronically increased blood glucose and multiple physiologic alterations that place them at elevated risk for vascular disease. Traditionally, this vascular risk has mainly referred to chronic atherosclerosis and embolic arterial disease. Retrospective studies have suggested an increased risk of a pulmonary embolism (PE) and deep vein thrombosis (DVT), collectively termed venous thromboembolism (VTE), in patients with DM, but this association has been difficult to demonstrate with comorbidities such as obesity in meta-analysis. Clinical studies have demonstrated worse outcomes for patients with DM who suffer from VTE. In vitro studies show multiple physiologic abnormalities with chronic inflammation, endothelial dysfunction, dysfunction in the coagulation cascade, as well as other changes that drive a vicious cycle of hypercoagulability. Aggressive medical management of DM can improve vascular outcomes, and some anti-hyperglycemic therapies may modify VTE risk as well. Anticoagulation strategies are similar for patients with DM, but with some added considerations, such as high rates of comorbid renal dysfunction. More research is needed to definitively categorize DM as a risk factor for VTE and elucidate specific therapeutic strategies.<\/jats:p>","DOI":"10.3390\/diagnostics14171994","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T09:21:00Z","timestamp":1725873660000},"page":"1994","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hyperglycemia and Venous Thromboembolism"],"prefix":"10.3390","volume":"14","author":[{"given":"Neha","family":"Panchagnula","sequence":"first","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Philip","family":"Brasher","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous Thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1160\/TH17-08-0531","article-title":"Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing Mortality","volume":"118","author":"Lehnert","year":"2018","journal-title":"Thromb. Haemost."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Li, X., Weber, N.C., Cohn, D.M., Hollmann, M.W., DeVries, J.H., Hermanides, J., and Preckel, B. (2021). Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112419"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF00284459","article-title":"Venous Thrombosis in Diabetes Mellitus","volume":"25","author":"Jones","year":"1983","journal-title":"Diabetologia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00125-005-1715-5","article-title":"The Risk of Venous Thromboembolism Is Markedly Elevated in Patients with Diabetes","volume":"48","author":"Petrauskiene","year":"2005","journal-title":"Diabetologia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa022157","article-title":"An Association between Atherosclerosis and Venous Thrombosis","volume":"348","author":"Prandoni","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular Risk Factors and Venous Thromboembolism","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Charlier, S.H.R., Meier, C., Jick, S.S., Meier, C.R., and Becker, C. (2022). Association between Glycemic Control and Risk of Venous Thromboembolism in Diabetic Patients: A Nested Case\u2013Control Study. Cardiovasc. Diabetol., 21.","DOI":"10.1186\/s12933-021-01432-1"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Deischinger, C., Dervic, E., Nopp, S., Kaleta, M., Klimek, P., and Kautzky-Willer, A. (2022). Diabetes Mellitus Is Associated with a Higher Relative Risk for Venous Thromboembolism in Females than in Males. Diabetes Res. Clin. Pract., 194.","DOI":"10.1016\/j.diabres.2022.110190"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2015.10.019","article-title":"Diabetes Mellitus and Venous Thromboembolism: A Systematic Review and Meta-Analysis","volume":"111","author":"Bell","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejim.2015.10.001","article-title":"Is Diabetes Mellitus a Risk Factor for Venous Thromboembolism? A Systematic Review and Meta-Analysis of Case-Control and Cohort Studies","volume":"28","author":"Gariani","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ding, C., Guo, C., Du, D., Gong, X., and Yuan, Y. (2023). Association between Diabetes and Venous Thromboembolism: A Systematic Review and Meta-Analysis. Medicine, 102.","DOI":"10.1097\/MD.0000000000035329"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Xie, W., Wang, Y., Xiao, S., Qiu, L., Yu, Y., and Zhang, Z. (2022). Association of Gestational Diabetes Mellitus with Overall and Type Specific Cardiovascular and Cerebrovascular Diseases: Systematic Review and Meta-Analysis. BMJ, 378.","DOI":"10.1136\/bmj-2022-070244"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00592-018-1112-4","article-title":"The Risk of Type 2 Diabetes Mellitus According to the Categories of Body Mass Index: The Korean Genome and Epidemiology Study (KoGES)","volume":"55","author":"Jung","year":"2018","journal-title":"Acta Diabetol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10654-017-0251-1","article-title":"Lipid Levels and Risk of Venous Thrombosis: Results from the MEGA-Study","volume":"32","author":"Morelli","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gregson, J., Kaptoge, S., Bolton, T., Pennells, L., Willeit, P., Burgess, S., Bell, S., Sweeting, M., Rimm, E.B., and Kabrhel, C. (2019). Cardiovascular Risk Factors Associated with Venous Thromboembolism. JAMA Cardiol., 4.","DOI":"10.1001\/jamacardio.2018.4537"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/CIRCULATIONAHA.118.038137","article-title":"Excess Cardiovascular Risk in Type 1 Diabetes Mellitus","volume":"139","author":"Petrie","year":"2019","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hinton, W., Nemeth, B., de Lusignan, S., Field, B., Feher, M.D., Munro, N., Roberts, L.N., Arya, R., and Whyte, M.B. (2021). Effect of Type 1 Diabetes and Type 2 Diabetes on the Risk of Venous Thromboembolism. Diabet. Med., 38.","DOI":"10.1111\/dme.14452"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Peng, Y.H., Lin, Y.S., Chen, C.H., Tsai, K.Y., Hung, Y.C., Chen, H.J., Liao, W.C., and Ho, W.C. (2020). Type 1 Diabetes Is Associated with an Increased Risk of Venous Thromboembolism: A Retrospective Population-Based Cohort Study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0226997"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.arth.2008.10.002","article-title":"Preadmission Hyperglycemia Is an Independent Risk Factor for In-Hospital Symptomatic Pulmonary Embolism after Major Orthopedic Surgery","volume":"25","author":"Mraovic","year":"2010","journal-title":"J. Arthroplast."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/dc11-1379","article-title":"Elevated Admission Glucose and Mortality in Patients with Acute Pulmonary Embolism","volume":"35","author":"Scherz","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jdiacomp.2016.06.019","article-title":"Blood Glucose on Admission and Mortality in Patients with Venous Thromboembolism","volume":"31","author":"Akirov","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Altabas, V., Pukec, L., Mlinari\u0107, S., Pintari\u0107, H., and \u0160iki\u0107, A. (2020). Stress Hyperglycaemia Indicates Embolus Size and Localization in Patients with Acute Pulmonary Embolism. Int. J. Endocrinol., 2020.","DOI":"10.1155\/2020\/3606757"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/jdi.13710","article-title":"Diabetes Mellitus and Its Impact on Mortality Rate and Outcome in Pulmonary Embolism","volume":"13","author":"Schmitt","year":"2022","journal-title":"J. Diabetes Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/resp.12847","article-title":"Type 2 Diabetes Is Associated with a Higher Incidence of Hospitalization for Pulmonary Embolism in Spain: Analysis of Hospital Discharge Data during 2004\u20132013","volume":"21","author":"Monreal","year":"2016","journal-title":"Respirology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejim.2018.08.001","article-title":"Mortality after Pulmonary Embolism in Patients with Diabetes. Findings from the RIETE Registry","volume":"59","author":"Lorenzo","year":"2019","journal-title":"Eur. J. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1080\/03007995.2021.1947215","article-title":"Development and Validation of a Claims-Based Model to Identify Patients at Risk of Chronic Thromboembolic Pulmonary Hypertension Following Acute Pulmonary Embolism","volume":"37","author":"Kanwar","year":"2021","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1160\/TH13-02-0097","article-title":"Factors Associated with Diagnosis and Operability of Chronic Thromboembolic Pulmonary Hypertension","volume":"110","author":"Lang","year":"2013","journal-title":"Thromb. Haemost."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2014.11.003","article-title":"Diabetes Is Associated with Increased Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis","volume":"135","author":"Bai","year":"2015","journal-title":"Thromb. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.vph.2012.06.004","article-title":"The Diverse Ligand Repertoire of the Receptor for Advanced Glycation Endproducts and Pathways to the Complications of Diabetes","volume":"57","author":"Ramasamy","year":"2012","journal-title":"Vascul. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mitroi, R., Padureanu, V., Mitrea, A., Timofticiuc, D.C.P., Rosu, M.M., Clenciu, D., Enescu, A., Padureanu, R., Tenea Cojan, T.S., and Vladu, I.M. (2023). Prothrombotic Status in COVID-19 with Diabetes Mellitus (Review). Biomed. Rep., 19.","DOI":"10.3892\/br.2023.1647"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of Reactive Oxygen Species and NF-\u039aB Signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/JME-20-0128","article-title":"Netosis Contributes to the Pathogenesis of Diabetes and Its Complications","volume":"65","author":"Njeim","year":"2020","journal-title":"J. Mol. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil Extracellular Traps Kill Bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, Complement, and Coagulation: A Triangular Relationship","volume":"16","author":"Boelens","year":"2019","journal-title":"Cell Mol. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, P., Lozano, P., Ros, G., and Solano, F. (2023). Hyperglycemia and Oxidative Stress: An Integral, Updated and Critical Overview of Their Metabolic Interconnections. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119352"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gutmann, C., Siow, R., Gwozdz, A.M., Saha, P., and Smith, A. (2020). Reactive Oxygen Species in Venous Thrombosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061918"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kearney, K., Tomlinson, D., Smith, K., and Ajjan, R. (2017). Hypofibrinolysis in Diabetes: A Therapeutic Target for the Reduction of Cardiovascular Risk. Cardiovasc. Diabetol., 16.","DOI":"10.1186\/s12933-017-0515-9"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1111\/jth.12935","article-title":"Basic Mechanisms and Regulation of Fibrinolysis","volume":"13","author":"Longstaff","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s001250050743","article-title":"Fibrinogen, Fibrinolysis and Diabetes Mellitus: A Comment","volume":"40","author":"Vague","year":"1997","journal-title":"Diabetologia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1177\/1076029618792304","article-title":"Glucose Concentration Affects Fibrin Clot Structure and Morphology as Evidenced by Fluorescence Imaging and Molecular Simulations","volume":"24","author":"Hood","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gough, S.C.L., and Juhan-Vague, I. (2019). Hypofibrinolysis and hyperinsulinemia. Fibrinolysis in Disease Molecular and Hemovascular Aspects of Fibrinolysis, CRC Press.","DOI":"10.1201\/9780367812829-22"},{"key":"ref_43","first-page":"469","article-title":"Shortened Activated Partial Thromboplastin Time and Increased Superoxide Dismutase Levels Are Associated with Type 2 Diabetes Mellitus","volume":"48","author":"Fu","year":"2018","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/jth.14573","article-title":"Glucose Metabolism Affects Coagulation Factors: The NEO Study","volume":"17","author":"Lijfering","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1160\/TH16-09-0716","article-title":"Obesity\/Insulin Resistance Rather than Liver Fat Increases Coagulation Factor Activities and Expression in Humans","volume":"117","author":"Lallukka","year":"2017","journal-title":"Thromb. Haemost."},{"key":"ref_46","unstructured":"Dayer, M.R., Mard-Soltani, M., Dayer, M.S., and Alavi, S.M.R. (2014). Causality Relationships between Coagulation Factors in Type 2 Diabetes Mellitus: Path Analysis Approach. Med. J. Islam. Repub. Iran, 28."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Xin, G., Wei, Z., Ji, C., Zheng, H., Gu, J., Ma, L., Huang, W., Morris-Natschke, S.L., Yeh, J.-L., and Zhang, R. (2016). Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and MtDNA Release. Sci. Rep., 6.","DOI":"10.1038\/srep36222"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1210\/jc.2007-0933","article-title":"Circulating Tissue Factor Procoagulant Activity and Thrombin Generation in Patients with Type 2 Diabetes: Effects of Insulin and Glucose","volume":"92","author":"Boden","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1753-0407.12521","article-title":"Macro- and Microvascular Endothelial Dysfunction in Diabetes","volume":"9","author":"Shi","year":"2017","journal-title":"J. Diabetes"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0003319717732238","article-title":"Endothelial Dysfunction and Venous Thrombosis","volume":"69","author":"Poredos","year":"2018","journal-title":"Angiology"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Carrizzo, A., Izzo, C., Oliveti, M., Alfano, A., Virtuoso, N., Capunzo, M., Di Pietro, P., Calabrese, M., De Simone, E., and Sciarretta, S. (2018). The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102968"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2337\/diabetes.55.02.06.db05-1103","article-title":"Loss of Endothelial Glycocalyx During Acute Hyperglycemia Coincides with Endothelial Dysfunction and Coagulation Activation In Vivo","volume":"55","author":"Nieuwdorp","year":"2006","journal-title":"Diabetes"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Meza, C.A., La Favor, J.D., Kim, D.H., and Hickner, R.C. (2019). Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153775"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Han, Y., Xie, H., Liu, Y., Gao, P., Yang, X., and Shen, Z. (2019). Effect of Metformin on All-Cause and Cardiovascular Mortality in Patients with Coronary Artery Diseases: A Systematic Review and an Updated Meta-Analysis. Cardiovasc. Diabetol., 18.","DOI":"10.1186\/s12933-019-0900-7"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.14740\/jem848","article-title":"Protective Effect of Metformin on Venous Thrombosis in Diabetic Patients: Findings from a Systematic Review","volume":"12","author":"Alqahtani","year":"2022","journal-title":"J. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6S44","DOI":"10.1016\/S1262-3636(03)72787-6","article-title":"Beneficial Effects of Metformin on Haemostasis and Vascular Function in Man","volume":"29","author":"Grant","year":"2003","journal-title":"Diabetes Metab."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Trujillo, J.M., Nuffer, W., and Smith, B.A. (2021). GLP-1 Receptor Agonists: An Updated Review of Head-to-Head Clinical Studies. Ther. Adv. Endocrinol. Metab., 12.","DOI":"10.1177\/2042018821997320"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/STROKEAHA.121.038151","article-title":"Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists","volume":"53","author":"Goldenberg","year":"2022","journal-title":"Stroke"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.122.059595","article-title":"GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients with Type 2 Diabetes","volume":"146","author":"Marx","year":"2022","journal-title":"Circulation"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00125-013-3145-0","article-title":"Glucagon-like Peptide 1 Analogue Therapy Directly Modulates Innate Immune-Mediated Inflammation in Individuals with Type 2 Diabetes Mellitus","volume":"57","author":"Hogan","year":"2014","journal-title":"Diabetologia"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Branchford, B.R., and Carpenter, S.L. (2018). The Role of Inflammation in Venous Thromboembolism. Front. Pediatr., 6.","DOI":"10.3389\/fped.2018.00142"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Wang, A., Yang, K., Wang, T., Zhang, N., Tang, H., and Feng, X. (2020). Effects of Sodium-glucose Cotransporter 2 Inhibitors on Risk of Venous Thromboembolism in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis. Diabetes Metab. Res. Rev., 36.","DOI":"10.1002\/dmrr.3174"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e3198","DOI":"10.1210\/clinem\/dgab124","article-title":"Lifestyle Intervention Improves Prothrombotic Coagulation Profile in Individuals at High Risk for Type 2 Diabetes","volume":"106","author":"Lehmann","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.soard.2018.03.022","article-title":"Effects of Gastric Bypass Followed by a Randomized Study of Physical Training on Markers of Coagulation Activation, Fibrin Clot Properties, and Fibrinolysis","volume":"14","author":"Stolberg","year":"2018","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s11239-017-1473-5","article-title":"Diabetes Mellitus Is Associated with Increased Bleeding in Pulmonary Embolism Receiving Conventional Anticoagulant Therapy: Findings from a \u201cReal-World\u201d Study","volume":"43","author":"Zhang","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.amjmed.2011.12.004","article-title":"Venous Thromboembolism in Patients with Diabetes Mellitus","volume":"125","author":"Piazza","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijcard.2018.12.019","article-title":"Impact of Symptomatic Atherosclerosis in Patients with Pulmonary Embolism","volume":"278","author":"Keller","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/dc13-1586","article-title":"Proliferative Retinopathy in Type 1 Diabetes Is Associated with Cerebral Microbleeds, Which Is Part of Generalized Microangiopathy","volume":"37","author":"Woerdeman","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in Patients with Atrial Fibrillation: A Meta-Analysis of Randomised Trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Coleman, C.I., Costa, O.S., Brescia, C.W., Vardar, B., Abdelgawwad, K., and Sood, N. (2021). Thromboembolism, Bleeding and Vascular Death in Nonvalvular Atrial Fibrillation Patients with Type 2 Diabetes Receiving Rivaroxaban or Warfarin. Cardiovasc. Diabetol., 20.","DOI":"10.1186\/s12933-021-01250-5"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1111\/dom.13371","article-title":"Should We Still Be Utilizing Warfarin in the Type 2 Diabetic Patient?","volume":"20","author":"Bell","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Camm, A.J., Sabbour, H., Schnell, O., Summaria, F., and Verma, A. (2022). Managing Thrombotic Risk in Patients with Diabetes. Cardiovasc. Diabetol., 21.","DOI":"10.1186\/s12933-022-01581-x"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/17\/1994\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:52:12Z","timestamp":1760111532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/17\/1994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":72,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["diagnostics14171994"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14171994","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]}}}